UNICHEMLABNSEUnichem Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 13 Apr · 15:06 IST

Unichem Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

UNICHEMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.1%1-day move
₹343.10
prior close
₹338.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.1-0.3+1.1+1.9+2.0+1.0+0.9+11.9+12.2+5.6+28.8+74.7
Up moveDown movePending
AI summary

Unichem Laboratories' Promoter and Promoter Group (7 entities including Dr. Prakash Amrut Mody, his family members, and three trusts) have submitted a nil-encumbrance declaration to the stock exchanges for the financial year ending 31st March 2026. This means no shares held by the promoter group were pledged, hypothecated, or used as collateral during this period. The disclosure covers all seven promoter entities listed, confirmed by Dr. Prakash Mody as Promoter on behalf of the group. This is a routine regulatory compliance filing required under SEBI's takeover regulations.

Likely market impact

No promoter share encumbrances is a positive signal — it indicates lower risk for minority shareholders and no threat of forced sale of promoter-held shares, which can be dilutive or destabilising to the stock.